FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Delhivery IPO and Supriya Lifescience IPO.
Delhivery IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Supriya Lifescience IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Delhivery IPO | Supriya Lifescience IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Kotak Mahindra Capital Company Limited Morgan Stanley India Company Pvt Ltd Bofa Securities India Limited Citigroup Global Markets India Private Limited |
Axis Capital Limited ICICI Securities Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Delhivery IPO is up to ₹5,235.00 Cr whereas the issue size of the Supriya Lifescience IPO is up to ₹700.00 Cr. The final issue price of Delhivery IPO is ₹487.00 per share and of Supriya Lifescience IPO is ₹274.00 per share.
Delhivery IPO | Supriya Lifescience IPO | |
---|---|---|
Face Value | ₹1 per share | ₹2 per share |
Issue Price (Lower) | ₹462.00 per share | ₹265.00 per share |
Issue Price (Upper) | ₹487.00 per share | ₹274.00 per share |
Issue Price (Final) | ₹487.00 per share | ₹274.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹25.00 per share | |
Market Lot Size | 30 shares | 54 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹4,000.00 Cr | up to ₹200.00 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | up to ₹1,235.00 Cr | up to ₹500.00 Cr |
Issue Size Total | ||
Issue Size Total (Amount) | up to ₹5,235.00 Cr | up to ₹700.00 Cr |
Delhivery IPO opens on May 11, 2022, while Supriya Lifescience IPO opens on Dec 16, 2021. The closing date of Delhivery IPO and Supriya Lifescience IPO is May 13, 2022, and Dec 20, 2021, respectively.
Delhivery IPO | Supriya Lifescience IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | May 11, 2022 | Dec 16, 2021 |
Issue Close | May 13, 2022 | Dec 20, 2021 |
Basis Of Allotment (Tentative) | May 19, 2022 | Dec 23, 2021 |
Initiation of Refunds (Tentative) | May 20, 2022 | Dec 24, 2021 |
Credit of Share (Tentative) | May 23, 2022 | Dec 27, 2021 |
Listing date (Tentative) | May 24, 2022 | Dec 28, 2021 |
Anchor Lockin End date 1 | Jun 18, 2022 | Jan 22, 2022 |
Anchor Lockin End date 2 | Aug 17, 2022 | Mar 23, 2022 |
Delhivery IPO P/E ratio is -67.3, as compared to Supriya Lifescience IPO P/E ratio of .
Delhivery IPO | Supriya Lifescience IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.98% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 68.24% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | -67.3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹35283.22 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Delhivery IPO retail investors (RII) are offered 1,12,87,878 shares while in Supriya Lifescience IPO retail investors are offered 1,12,87,878 shares. Qualified institutional buyers (QIB) are offered 3,38,63,662 shares in Delhivery IPO and 79,24,527 shares in Supriya Lifescience IPO.
Delhivery IPO | Supriya Lifescience IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 3,38,63,662 shares | 79,24,527 shares |
NII | 1,69,31,818 shares | 39,62,263 shares |
RII | 1,12,87,878 shares | 26,41,509 shares |
Employee | 4,57,665 shares | 0 shares |
Others | ||
Total | 6,25,41,023 shares | 1,45,28,299 shares |
Delhivery IPO subscribed 1.63x in total, whereas Supriya Lifescience IPO subscribed 71.51x.
Delhivery IPO | Supriya Lifescience IPO | |
---|---|---|
QIB (times) | 2.66x | 31.83x |
NII (times) | 0.30x | 161.22x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 0.57x | 56.01x |
Employee (times) | 0.27x | |
Other (times) | 0.00x | |
Total (times) | 1.63x | 71.51x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|